A new autoantibody to valyl transfer RNA synthetase associated with anti-synthetase syndrome.
A new autoantibody to valyl transfer RNA synthetase associated with anti-synthetase syndrome.
复制标题
一种新的与抗合成酶综合征相关的缬氨酰转移 RNA 合成酶自身抗体。
DOI:
10.1093/rheumatology/keac569
复制
发表时间:
2022
期刊:
影响因子:
--
通讯作者:
Morinobu A.
中科院分区:
文献类型:
--
作者:
Sasai T;Nakashima R;Shirakashi M;Hiwa R;Tsuji H;Kitagori K;Akizuki S;Yoshifuji H;Mimori T;Morinobu A.
DEAR EDITOR, The aminoacyl tRNA synthetase (ARS) antibody is the most frequently detected myositis-specific autoantibody in idiopathic inflammatory myopathy [1]. ARS antibody-positive patients frequently have myositis, as well as interstitial lung disease (ILD), polyarthritis, RP, fever and mechanic’s hands. Together, these symptoms define antisynthetase syndrome (ASSD)[2]. ARS binds amino acids to tRNA in the presence of adenosine triphosphate and catalyses the synthesis of aminoacyl tRNA. In humans, there are 20 different types of ARSs, one for each amino acid. Eight of these tRNA synthetases have been reported as myositis-specific autoantigens [3][Jo-1 (histidyl), PL-7 (threonyl), PL-12 (alanyl), EJ (glycyl), OJ (isoleucyl), KS (asparaginyl), Zo (phenylalanyl), and Ha (tyrosyl)] and are associated with the ASSD phenotype, with the latter two being the least commonly involved [4, 5]. In this study we identified a new anti-ARS directed against valyl tRNA synthetase (VRS) in a patient with typical features of ASSD. A 43-year-old man was admitted to our hospital with occasional fever, myalgia and arthralgia lasting 2months. He also reported RP. Physical examination revealed swollen fingers and weakness of the deltoid and quadriceps muscles. Laboratory studies revealed the following: lactate dehydrogenase, 732 U/l; creatine phosphokinase (CK), 2472 U/l; aldolase, 46.4 IU/l; CRP, 1.5 mg/dl; and Krebs von den Lungen-6, 396 U/ml. Fluorescent ANA was also positive (titre 1: 640, with a nucleolar and cytoplasmic pattern) but disease-specific autoantibodies were negative. Chest CT revealed ILD, with a pattern classified as a non-specific interstitial pneumonia. Fat-saturated T2-weighted MRI revealed diffuse high-intensity signals in the deltoid and iliopsoas muscles and needle electromyography of these muscles revealed myogenic changes. A muscle biopsy of the left quadriceps femoris showed necrotic muscle fibres and endomysial infiltration of mononuclear cells, consistent with myositis. Based on these findings, the patient was clinically diagnosed with ASSD. CT also revealed a swollen mediastinal lymph node that was pathologically diagnosed as an undifferentiated carcinoma. Immunohistochemical analysis of the lymph node did not identify it as a lymphoma, sarcoma or specific type of carcinoma. 18F-fluorodeoxyglucose PET did not reveal any lesions other than the swollen mediastinal lymph node. Thus the patient was diagnosed with ASSD coexisting with a cancer of unknown origin.The patient was treated for cancer of unknown origin with chemotherapy (carboplatin and paclitaxel) and concurrent radiotherapy. The CK value peaked at the beginning of chemotherapy and gradually decreased with cancer treatment. He died of cancer 8 months after the first admission. This case was consistent with ASSD, but the patient’s serum did not show any known disease-specific autoantibodies. However, we found that the serum precipitated some autoantigens by RNA immunoprecipitation (IP) and protein IP. Analysis of RNA IP from HeLa cell extracts with urea–10% polyacrylamide gel electrophoresis and silver staining showed a band corresponding to tRNA, which differed from those precipitated by previously reported ARS antibodies (Fig. 1A). Analysis of protein IP using proteins extracted from 35S-labelled HeLa cells with sodium dodecyl sulphate–8% polyacrylamide gel electrophoresis revealed a 140-kDa protein precipitated, different from those reported previously, such as melanoma differentiation-associated gene 5 (Fig. 1B). Among the 20 ARS enzymes, VRS was listed as a candidate antigen based on its molecular weight, therefore we …